Acquired temozolomide resistance in MGMT-deficient glioblastoma cells is associated with regulation of DNA repair by DHC2

The acquisition of temozolomide resistance is a major clinical challenge for glioblastoma treatment. Chemoresistance in glioblastoma is largely attributed to repair of temozolomide-induced DNA lesions by O(6)-methylguanine-DNA methyltransferase (MGMT). However, some MGMT-deficient glioblastomas are...

Descripción completa

Detalles Bibliográficos
Autores principales: Yi, Guo-zhong, Huang, Guanglong, Guo, Manlan, Zhang, Xi’an, Wang, Hai, Deng, Shengze, Li, Yaomin, Xiang, Wei, Chen, Ziyang, Pan, Jun, Li, Zhiyong, Yu, Lei, Lei, Bingxi, Liu, Yawei, Qi, Songtao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6658867/
https://www.ncbi.nlm.nih.gov/pubmed/31347685
http://dx.doi.org/10.1093/brain/awz202

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6658867/
https://www.ncbi.nlm.nih.gov/pubmed/31347685
http://dx.doi.org/10.1093/brain/awz202

Ejemplares similares